Danaher Corp (NYSE:DHR)
$ 253.38 1.95 (0.78%) Market Cap: 187.68 Bil Enterprise Value: 198.81 Bil PE Ratio: 42.95 PB Ratio: 3.51 GF Score: 83/100

Danaher Corp at Bank of America Merrill Lynch Health Care Conference Transcript

May 15, 2019 / 03:00PM GMT
Release Date Price: $116.16 (+0.23%)
Michael Leonidovich Ryskin
BofA Merrill Lynch, Research Division - Associate

My name is Mike Ryskin. I'm on the life sciences tools and diagnostics team here at Bank of America Merrill Lynch. I work with Derik de Bruin, the senior analyst. Unfortunately, he can't make it today, but he's following via the webcast, and he sends his best to everyone. With us today, we have Matt McGrew, CFO of Danaher; and Rainer Blair, EVP of the Life Sciences division. Before we get started, the mandatory [II] request voting season has started. Derik would greatly appreciate your support. I would appreciate your support, the entire tools team and all the other research analysts at the bank if you found our research useful. And if you didn't find our research useful, we would still appreciate your vote. And with that, we'll start with a short presentation by Rainer and then we'll go into a fireside chat format.

Rainer M. Blair
Danaher Corporation - EVP

Thanks, Mike. Ready to go. Okay. Well, good morning, everybody. Thanks for making it to an 8:00 a.m. meeting here in Vegas. That

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot